Urology Today.net

Site updated at Thursday, 12 May 2016

Common Urological Problems

Zetia

FDA fails to approve cholesterol drug for kidney disease

U.S. health regulators amended the prescribing label for Merck & Co’s cholesterol-lowering drug Vytorin to show it prevents heart problems in patients with chronic kidney disease, but stopped short of approving its use for that purpose.

The decision means Merck cannot market Vytorin as a treatment for reducing the rate of heart problems in… FDA fails to approve cholesterol drug for kidney disease   



dana-farber cancer institute1 - ovulatory cycle1 - nsaids1 - chronic dialysis1 - bladder infections1 - renal arteries2 - prostate cancer recurrence1 - chronic interstitial nephritis1 - renal artery stenosis1 - spop gene1 - congenital disorders1 - genitofemoral nerve1 - prognostic indicator1 - uric acid7 - department of urology2 - diabetes treatment1 - urinary system2 - risk of prostate cancer2 - uremia1 - adequate erection1 - renal tomography4 - hemolytic uremic syndrome1 - cardiorenal syndrome1 - renal tubules1 - catheter infection1 - urine levels1 - renal tumors1 - low-grade prostate cancer2 - prostate mri guidelines1 - computational biology1 -